Relevance of CYP2B6 and CYP2D6 genotypes to methadone pharmacokinetics and response in the OPAL study.
Caroline Victorri-VigneauCéline VerstuyftRégis BouquiéEdouard-Jules LaforgueJean-Benoit HardouinJuliette LeboucherBertrand Le GeayCorine DanoGaëlle Challet-BoujuMarie Grall-BronnecPublished in: British journal of clinical pharmacology (2019)
The genotyping of CYP2B6 G516T could be an interesting tool to explore methadone intervariability.